DELANEY HOLTHAUS: Open Payments
NPI 1891520987 · TOPEKA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$853 in 51 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $112 · 2025 $853
Food & beverage: $853
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $206 |
| Lilly USA, LLC | 8 | $167 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $125 |
| Novo Nordisk Inc | 6 | $112 |
| PFIZER INC. | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Exact Sciences Corporation | 2 | $32 |
| Medtronic, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Amgen Inc. | 1 | $17 |
Products named: UBRELVY, CAPLYTA, JARDIANCE, MOUNJARO, Ozempic, QULIPTA, PREVNAR 20, Wegovy.
Industry payments across KS — which companies pay providers there.
